Clinical Trials Browser

Phase 3 × Active not recruiting × irinotecan sucrosofate × Clear all

NCT06625320 2025-12-12

RASolute 302

Phase 3 Active not recruiting

Gastrointestinal

Pancreatic Neoplasms